#Global Western Blotting Industry Analysis

[tamanna31]

Home Infusion Therapy Market Size, Share, Growth, Analysis Forecast to 2030

Home Infusion Therapy Industry Overview

The global home infusion therapy market size was valued at USD 35.96 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030.

Home infusion therapy involves delivering therapeutic treatments, medications, or fluids directly into a patient's bloodstream through intravenous (IV) infusion, usually in the comfort and convenience of their home.

The growth of the market is driven by several key factors, including the expanding geriatric population characterized by decreased mobility, a rising preference for home care, and the swift evolution of technological advancements. Infusion therapy, encompassing essential components like IV therapy and IV hydration therapy, plays a crucial role in addressing conditions such as immune deficiencies, cancer, and congestive heart failure, where oral medication is not a viable treatment option. The increasing demand for these therapies stems from the need for long-term treatment among patients, positioning home infusion therapy as a notably cost-effective alternative to hospital-based care. The incorporation of IV therapy and IV hydration therapy serves as a driving force, providing patients with enhanced accessibility to effective and personalized medical solutions in the comfort of their homes

Gather more insights about the market drivers, restrains and growth of the Home Infusion Therapy Market

The home infusion market experienced a positive shift during the COVID-19 pandemic, with home infusion becoming a crucial necessity as healthcare facilities faced a surge in COVID patients. Despite the challenges posed by regional and country-wide lockdowns, causing disruptions in operations and supply chains, the market witnessed a substantial increase in 2020. As reported by Medtech Dive in October 2020, Baxter disclosed third-quarter sales of USD 2.97 billion, marking a 4% growth attributed to the rising demand for its COVID-related medical products. Furthermore, Baxter reported operational sales growth of 6% (reaching 3.2 billion) in Q3 2021 compared to 3.0 billion in Q3 2020, indicating a sustained recovery from the pandemic's impact.

Moreover, the market's expansion is propelled by the enhanced outcomes observed in patients and the cost-effectiveness and convenience provided by home infusion therapy. The increasing demographic of baby boomers struggling with diminished mobility due to conditions such as paralysis, osteoarthritis, and diabetes is expected to amplify the demand for home infusion therapy. The growing imperative to reduce the duration of inpatient stays is a pivotal factor poised to contribute significantly to the market's growth. Remarkably, continuous subcutaneous (SC) apomorphine infusion emerges as an exceptionally effective treatment for Parkinson's disease (PD), with diverse drug formulations available for the management of PD through subcutaneous delivery. In response to the mounting burden of PD, there is a notable surge in the demand for subcutaneous infusion therapy. For instance, in line with the Parkinson's Foundation's 2022 data update, approximately 90,000 individuals receive a PD diagnosis annually in the U.S. Furthermore, the anticipated number of people living with PD in the country is projected to soar to nearly 1.2 million by the year 2030.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global knee braces market size was valued at USD 1.12 billion in 2023 and is projected to grow at a CAGR of 7.7% from 2024 to 2030.

• The global western blotting market size was valued at USD 986.2 million in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2030.

Key Companies & Market Share Insights

Some of the key players operating in the market include Baxter, BD, Smiths Medical, Terumo Corporation, ICU Medical, etc

Baxter International Inc., commonly known as Baxter, is a global healthcare company that specializes in providing a wide range of medical products, therapies, and technologies. With a rich history dating back to the 1930s, Baxter has evolved into a leading player in the healthcare industry. The company develops innovative solutions for critical medical needs, including renal care, medication delivery, pharmaceuticals, and various therapeutic areas.

Becton, Dickinson and Company (BD) is a global medical technology company. BD specializes in developing and manufacturing medical devices, laboratory equipment, and diagnostic products aimed at advancing the diagnosis and treatment of various medical conditions. With a commitment to improving healthcare outcomes, BD focuses on delivering solutions in areas such as medication management, infection prevention, diagnostics, and biosciences.

Key Home Infusion Therapy Companies:

CVS/Coram

Option Care Health

BriovaRx/Diplomat (UnitedHealth Optum)

PharMerica

Fresenius Kabi

ICU Medical, Inc.

B. Braun Melsungen AG

Baxter

BD

Caesarea Medical Electronics

Smiths Medical

Terumo Corporation

JMS Co. Ltd.

Recent Developments

In June 2023, Baxter International, an American healthcare company, introduced Progressa+ Next Gen ICU bed for addressing critical needs of patients at their homes. This technology makes it easier for nurses to take care of patients, while supporting therapy at home.

In May 2023, Fresenius Kabi, a global healthcare company, initiated an agreement with Premier, Inc., an American healthcare company, that resulted in pricing and term benefits for the Ivenix Infusion System. This system is designed to advance the reliability and simplicity of infusion pumps.

In May 2023, Option Care Health, a healthcare service provider, created an independent platform for home care services in collaboration with Amedisys Inc., a leading provider of home health services. This platform comprises pharmacists, dieticians, therapists, social workers, and others for providing high quality healthcare services at home.

In April 2023, CareFusion, currently owned by Becton Dickinson, an American medical technology company, launched an advanced ultrasound technology to provide clinicians with optimal IV insertions. More than 90% hospitalized patients receive the IV therapy, thus contributing towards the market growth of home infusion therapy.

In January 2022, ICU Medical, a California-based global operations company, finalized the acquisition of Smiths Medical from Smiths Group Plc for creating a leading infusion therapy company with a combined revenue of USD 2.5 billion.

In November 2021, Terumo Corporation, a global medical device company, developed a smartphone device for controlling insulin pump. This device can be utilized as a home infusion therapy by patients for harmonizing the insulin therapy at home.

Order a free sample PDF of the Home Infusion Therapy Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Blood Screening Market Analysis, Opportunities And Forecast Report 2024-2030

The global blood screening market size was valued at USD 2.76 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% from 2023 to 2030. 

Blood screening is a process in which donated blood is screened for infectious diseases such as HBV, HCV, HIV1, and HIV2. The high growth of this market is attributed to rising blood donations, an increase in the incidence of infectious diseases, and government initiatives. According to World Health Organization (WHO), 118.54 million blood donations are collected yearly. In the U.S., 6.8 million individuals donate blood annually, and 13.6 million units of red blood cells and whole blood are collected annually.

Gather more insights about the market drivers, restrains and growth of the Blood Screening Market

The market is primarily driven by the rise in the rate of disorders such as HIV, diphtheria, measles and chronic diseases such as hemophilia, cancer, and other blood-related disorders. Blood-based diagnostics are used to diagnose a wide range of diseases, including infectious diseases, cancer, and cardiovascular diseases. Serology tests detect the presence of antibodies to a specific disease-causing organism. These tests diagnose various infectious diseases, including HIV, hepatitis B, and syphilis. Molecular tests detect the presence of DNA or RNA from a specific disease-causing organism. These tests are more sensitive than serology tests and can be used to diagnose diseases at an earlier stage. Biochemical tests measure the levels of certain substances in the blood. These tests can diagnose a wide range of diseases, including diabetes, kidney disease, and liver disease.

The COVID-19 pandemic had a significant impact on the market. Although respiratory droplets are the primary means of COVID-19 virus transmission, research has shown that viral RNA may be discovered in blood samples, supporting blood screening for COVID-19 identification, hence driving the market significantly. 

Blood Screening Market Segmentation

Grand View Research has segmented the global blood screening market based on technology, product, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Nucleic Acid Amplification Test (NAT)

• ELISA

• Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)

• Next Generation Sequencing

• Western Blotting

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Reagent

• Instrument

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Sweden

o Norway

o Denmark

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa

o Saudi Arabia

o South Africa

o UAE

o Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030. 

• The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. 

Key Companies & Market Share Insights

Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.

For instance, in March 2023, Abbott received U.S Food and Drug Administration (FDA) clearance for a laboratory traumatic brain injury blood test, the first commercially available lab-based test for the assessment of mild traumatic brain injuries (TBIs), commonly referred to as concussions, which will be made widely available to hospitals across the U.S. This test, which is powered by Abbott’s Alinity i laboratory tool, will enable clinicians to evaluate individuals with mild traumatic brain injuries in a timely manner.

Furthermore, in May 2023, Siemens Healthcare introduced Atellica HEMA 570 and 580 next-generation hematology analyzers, which have user-friendly interfaces and can be connected to multiple analyzers to remove workflow barriers and provide high throughput time.

Key Blood Screening Companies:

• Abbott

• Danaher Corporation (Beckman Coulter)

• Becton Dickinson and Company

• Bio-Rad Laboratories, Inc.

• Hoffman-La Roche Ltd.

• Grifols, S.A.

• Ortho-Clinical Diagnostics, Inc.

• Siemens Healthcare GmbH

• Thermo Fisher Scientific, Inc.

• SOFINA s.a (Biomerieux)

Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research. 

[bhushans]

Global Focus on Improved Outcomes: Global Neuro Immunoassay Market

The global neuro immunoassay market is poised for remarkable expansion, with projections indicating a surge to USD 5,303.1 million by 2033, according to recent market analysis. This forecast marks a substantial increase from its 2023 valuation of USD 2,616.1 million, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period.

Neuro immunoassay, a vital segment within the healthcare industry, plays a pivotal role in diagnosing and monitoring neurological disorders and autoimmune diseases. With advancements in technology and an evolving understanding of these conditions, the demand for accurate and efficient diagnostic tools is on the rise. Neuro immunoassay techniques offer a precise and reliable means of detecting biomarkers associated with various neurological and autoimmune conditions, driving their adoption across clinical settings worldwide.

Initiate In-Depth Research With Your Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-4293

The projected growth of the neuro immunoassay market underscores the increasing prevalence of neurological disorders and autoimmune diseases globally. As populations age and lifestyles evolve, the incidence of these conditions continues to escalate, necessitating advanced diagnostic solutions for timely intervention and management.

Key Takeaways:

The global neuro immunoassay market is expected to reach a value of US$5,303.1 million by 2033, reflecting a significant increase from US$2,616.1 million in 2023.

This growth is projected at a healthy compound annual growth rate (CAGR) of 7.3% during the forecast period.

The surge in demand is attributed to the crucial role of immunoassays in various applications like biopharmaceutical analysis, clinical diagnostics, and early disease detection.

Key Segments of the Neuro Immunoassay Market

By Technology:

Radioimmunoassays (RIA)

Polymerase Chain Reaction (PCR)

ELISA

Western Blot

Rapid Tests

ELISPOT

By Product Type:

Reagents and Kits

Analysers

By Application:

Alzheimer’s Disease

Parkinson’s Disease

Huntington’s Disease

Amyotrophic Lateral Sclerosis (ALS)

Spinal Muscular Atrophy (SMA)

By End User:

Hospitals

Clinics

Academic Organizations

Biopharmaceutical Companies

Pharmaceutical Companies

Others

By Region:

North America

Latin America

Asia Pacific

Middle East and Africa

Europe

[industryforecastnews]

Research Antibodies Market Size, Share & Growth Report, 2030

Research Antibodies Market Growth & Trends

The global research antibodies market size is expected to reach USD 2.21 billion by 2030, expanding at a CAGR of 4.76% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors driving the market include a rise in R&D activities undertaken by biopharmaceutical and biotechnology companies and increase in support from government authorities. Furthermore, expansion in the scope of neurobiology and stem cell research and the availability of technologically advanced antibody production methods are expected to propel market growth.

An increase in the number of collaborative initiatives undertaken by research institutes and various public and private entities for the promotion of cell-based research is fueling market growth. The trend is more prominent in established markets, such as North America, that have an established scientific infrastructure. For instance, in March 2020, the Canadian government invested around USD 4.3 million in funds towards the Centre for Commercialization of Regenerative Medicine, which is involved in carrying out scientific studies based on cell regeneration. Moreover, in April 2021, the government announced an investment of USD 45 million over 3 years in Stem Cell Network to develop information, therapies, and technologies to benefit individuals living with chronic and severe illnesses such as COVID-19 and assess its long-term impact. Such initiatives are expected to encourage further adoption of antibody activities and enhance the growth prospects for the market.

The COVID-19 outbreak has created lucrative growth opportunities for the market. Several leading pharmaceutical companies are investing significantly in R&D for creating effective testing tools and increasing scientific understanding of the disease. The need for research antibodies has greatly increased as a result of these intense R&D operations for the development of novel vaccination and therapy techniques. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibody therapy study for COVID-19.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/research-antibodies-market

Research Antibodies Market Report Highlights

In 2023, the primary product segment held the largest revenue share due to the higher specificity and direct detection capabilities offered by the antibodies

By type, monoclonal antibodies captured a substantial share in 2023 due to the increase in COVID-19-related research activities involving the use of such antibodies

The western blotting technology segment held a dominant share in 2023 because of the increasing investments in R&D activities by several biotechnology and pharmaceutical companies and the rapidly growing applications of antibodies in western blots created for proteomic studies

By end-use, academic and research institutions held the largest share in 2023 due to a rise in funding opportunities and growth in the number of scientific institutions involved in life sciences

In 2023, North America accounted for the largest share of over 39.15% due to the widespread presence of life sciences research institutions and numerous biotechnology and biopharmaceutical manufacturers inthe region

Research Antibodies Market Segmentation

Grand View Research has segmented the global research antibodies market on the basis of product, type, technology, source, application, end-use, and region:

Research Antibodies Product Outlook (Revenue, USD Billion, 2018 - 2030)

Primary Antibodies

Secondary Antibodies

Research Antibodies Type Outlook (Revenue, USD Billion, 2018 - 2030)

Monoclonal Antibodies

Polyclonal Antibodies

Research Antibodies Technology Outlook (Revenue, USD Billion, 2018 - 2030)

Immunohistochemistry

Immunofluorescence

Western Blotting

Flow Cytometry

Immunoprecipitation

ELISA

Others

Research Antibodies Source Outlook (Revenue, USD Billion, 2018 - 2030)

Mouse

Rabbit

Goat

Others

Research Antibodies Application Outlook (Revenue, USD Billion, 2018 - 2030)

Infectious Diseases

Immunology

Oncology

Stem Cells

Neurobiology

Others

Research Antibodies End Use Outlook (Revenue, USD Billion, 2018 - 2030)

Academic & Research Institutes

Contract Research Organizations

Pharmaceutical & Biotechnology Companies

Research Antibodies Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

S.

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Singapore

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Research Antibodies Market

Abcam Plc.

Merck KGaA

Thermo Fisher Scientific, Inc.

Cell Signalling Technology, Inc.

Santa Cruz Biotechnology Inc.

PerkinElmer, Inc.

Becton, Dickinson and Company

Bio-Techne Corporation

Proteintech Group, Inc.

Jackson ImmunoResearch Inc.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/research-antibodies-market

[blog-site-for-market-research]

Understanding Market Dynamics in the Autoimmune Disease Diagnostics Market Industry

Market Overview –

The size of the market for autoimmune disease diagnostics was estimated at USD 4.9 billion in 2022 and is expected to increase at a compound yearly growth rate (CAGR) of 6.7% from USD 5.23 billion in 2023 to USD 8.78 billion by 2032.

The autoimmune disease diagnostics market is witnessing growth driven by advancements in the diagnosis of lupus and other autoimmune conditions. With increasing awareness and understanding of these diseases, there's a rising demand for accurate and efficient diagnostic tools. Innovations in biomarker testing and imaging techniques are enhancing early detection and personalized treatment strategies, driving market expansion.

The autoimmune disease diagnostics market focuses on providing tools and tests for diagnosing autoimmune diseases, a group of conditions where the immune system attacks healthy cells and tissues. These diseases can affect various organs and systems in the body, leading to chronic inflammation, tissue damage, and functional impairment.

Market growth is driven by the increasing prevalence of autoimmune diseases worldwide, attributed to factors such as genetic predisposition, environmental triggers, and lifestyle factors. With millions of people affected by autoimmune diseases, there is a growing demand for accurate and timely diagnostic tests to facilitate early intervention and improve patient outcomes.

Technological advancements and innovations in autoimmune disease diagnostics are shaping the market, offering new biomarkers, imaging techniques, and molecular assays to enhance diagnostic accuracy and precision. From serological tests and genetic testing to advanced imaging modalities and point-of-care devices, these advancements enable healthcare providers to diagnose autoimmune diseases more effectively and tailor treatment strategies to individual patient needs.

Moreover, the growing recognition of the importance of early detection and personalized medicine is driving market growth, as healthcare systems prioritize preventive healthcare and precision diagnostics to improve patient care and reduce healthcare costs.

However, challenges such as variability in disease presentation, overlapping symptoms, and limited awareness among healthcare providers pose obstacles to market growth. Addressing these challenges requires greater education and training for healthcare professionals, improved access to diagnostic tools and resources, and collaboration between industry stakeholders to develop standardized diagnostic protocols and guidelines.

Segmentation –

The global autoimmune disease diagnostics market has been segmented on the basis of disease type, test type, and end-user.

The market, by disease type, has been classified as systemic autoimmune disease, and localized autoimmune disease. The systemic autoimmune disease segment has been further classified into psoriasis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus (SLE), and others. Localized autoimmune disease segment has been divided into inflammatory bowel disease, thyroid, type 1 diabetes, and others.

On the basis of test type, the market has been segregated into  western blotting, enzyme-linked immunosorbent assay (ELISA), double immune diffusion, dot blot, counter immune-electrophoresis, line blot, immunofluorescence assays (IFA), multiplex immunoassay, agglutination, and others.

The end-user segment has been divided into, has been segmented into hospitals, diagnostics centers, research laboratories, and others

Regional Analysis –

The autoimmune disease diagnostics market varies regionally due to differences in disease prevalence, diagnostic infrastructure, and healthcare expenditure. Developed regions like North America and Europe have a higher prevalence of autoimmune diseases and well-established diagnostic capabilities, leading to a robust market for autoimmune disease diagnostics. In contrast, developing regions face challenges such as limited access to specialized testing facilities and lower awareness of autoimmune diseases, resulting in underdiagnosis and undertreatment.

Moreover, variations in regulatory frameworks and reimbursement policies influence market dynamics across different regions. As the burden of autoimmune diseases continues to rise globally, there is a growing need for affordable and accessible diagnostic solutions, particularly in underserved regions. Collaborative efforts between healthcare stakeholders and diagnostic companies are essential to address regional disparities and improve patient outcomes in the autoimmune disease diagnostics market.

Key Players –

Autoimmune disease diagnostics companies include Siemens Healthcare Private Limited, bioMérieux SA, Bio-rad Laboratories, Beckman Coulter, AstraZeneca, EUROIMMUN AG, Hoffmann-la Roche, Inova Diagnostics, Myriad Genetics, Thermo Fisher Scientific, Trinity Biotech Plc., and Hemagen Diagnostics.

Related Reports –

Urinalysis Test

Celiac Disease Treatment

Healthcare Enterprise Software

Amniotic Membrane

For more information visit at MarketResearchFuture

[farhan7212]

Protein Purification and Isolation Market trends, and forecasts from 2024 to 2034

The Protein Purification and Isolation market report offered by Reports Intellect is meant to serve as a helpful means to evaluate the market together with an exhaustive scrutiny and crystal-clear statistics linked to this market. The report consists of the drivers and restraints of the Protein Purification and Isolation Market accompanied by their impact on the demand over the forecast period. Additionally, the report includes the study of prospects available in the market on a global level. With tables and figures helping evaluate the Global Protein Purification and Isolation market, this research offers key statistics on the state of the industry and is a beneficial source of guidance and direction for companies and entities interested in the market. This report comes along with an additional Excel data-sheet suite taking quantitative data from all numeric forecasts offered in the study.

Get Sample PDF Brochure @ https://www.reportsintellect.com/sample-request/2910932

Key players offered in the market: Thermo Fisher Scientific Merck KGaA Qiagen N.V. Agilent Technologies Bio-Rad Laboratories GE Healthcare Bio-Sciences Sigma-Aldrich Corporation Promega Corporation Abcam plc

Additionally, it takes account of the prominent players of the Protein Purification and Isolation market with insights including market share, product specifications, key strategies, contact details, and company profiles. Similarly, the report involves the market computed CAGR of the market created on previous records regarding the market and existing market trends accompanied by future developments. It also divulges the future impact of enforcing regulations and policies on the expansion of the Protein Purification and Isolation Market.

Scope and Segmentation of the Protein Purification and Isolation Market

The estimates for all segments including type and application/end-user have been provided on a regional basis for the forecast period from 2024 to 2034. We have applied a mix of bottom-up and top-down methods for market estimation, analyzing the crucial regional markets, dynamics, and trends for numerous applications. Moreover, the fastest & slowest growing market segments are pointed out in the study to give out significant insights into each core element of the market.

Protein Purification and Isolation Market Type Coverage: - Ultrafiltration Precipitation Chromatography Electrophoresis Western Blotting

Protein Purification and Isolation Market Application Coverage: - Drug Screening Biomarker Discovery Protein-protein Interaction Studies Diagnostics

Regional Analysis:

North America Country (United States, Canada) South America Asia Country (China, Japan, India, Korea) Europe Country (Germany, UK, France, Italy) Other Countries (Middle East, Africa, GCC)

Also, Get an updated forecast from 2024 to 2034.

Discount PDF Brochure @ https://www.reportsintellect.com/discount-request/2910932

The comprehensive report provides:

· Complete assessment of all opportunities and threats in the global market.

· Protein Purification and Isolation Market recent advancements and major events.

· A thorough study of business policies for the growth of the Protein Purification and Isolation Market leading players.

· Concluding study about the growth plot of Protein Purification and Isolation Market for upcoming years.

· Detailed understanding of Protein Purification and Isolation Market particular drivers, restraints, and major micro markets.

· Favorable impression inside vital technological and market latest trends hitting the Protein Purification and Isolation Market.

Reasons to Purchase Protein Purification and Isolation Market Research Report

· Develop a competitive approach based on the competitive landscape

· Build business strategy by identifying the high growth and attractive Protein Purification and Isolation market classifications

· Identify potential business partners, gaining targets and business buyers

· Design financial investment policies based on estimated high potential segments

· Prepare management and tactical presentations using the Protein Purification and Isolation market data

· Plan for new product promotion and portfolio in advance

Covid-19 Impact Analysis: Our research analysts are highly focused on the Protein Purification and Isolation Market covid-19 impact analysis. A whole chapter is dedicated to the covid-19 outbreak so that our clients get whole and sole details about the market ups & downs. With the help of our report the clients will get vast statistics as to when and where should they invest in the industry.

Contact Us: sales@reportsintellect.com Phone No: + 1-706-996-2486 US Address: 225 Peachtree Street NE, Suite 400, Atlanta, GA 30303

[delvenservices]

In Vitro Toxicology Market Competitive Landscape

In Vitro Toxicology Market, By Product (Assay (Western Blot, Tissue Culture), Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion), Industry (Pharmaceutical, Cosmetics) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Market Overview

Global in Vitro Toxicology market is anticipated to reach USD 10.8 billion in 2021 growing at a CAGR of 11.5% during the forecasting period, 2021-2028.

In vitro toxicology is a set of technique used to study and identify the effect of various toxins on bacteria and other organisms. As a result of these testing only a drug or chemical is verified for human use. There are various methods like cytotoxicity, toxicokinetics etc. It also leads to develop a dose response relationship.

With an increased research in the sector along with the recent opposition to animal testing are some of the factors that have supported long-term expansion for In Vitro Toxicology industry.

To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/in-vitro-toxicology-market-trends-forecast-till-2028

Key Findings

Global In Vitro Toxicology market is segmented into Product, Toxicity Endpoints, Industry and geography.

Product segment is segmented into Assay (Western Blot, Tissue Culture), Equipment, Assay Reagent, and Software

Toxicity Endpoints segment is segmented into ADME, Skin Irritation, Corrosion

Industry segment is segmented into Pharmaceutical, Cosmetics

Geographically, global In Vitro Toxicology market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/in-vitro-toxicology-market-trends-forecast-till-2028

Competitive Landscape

Key players in global In Vitro Toxicology market are

Thermo Fisher Scientific Inc. (US),

Eurofins Scientific SE (Luxembourg),

Covance (US),

Bio-Rad Laboratories, Inc. (US),

GE Healthcare (US),

Merck KGaA (Germany),

Charles River Laboratories International, Inc. (US),

 Catalent, Inc. (US),

Cyprotex (UK),

SGS S.A. (Switzerland),

BioRad Laboratories,

QIAGEN N.V. (Germany),

Promega Corporation (US),

Gentronix Limited (UK),

BioIVT (US),

MB Research Laboratories (US),

Creative Biolabs(US),

GVK Biosciences Private Limited (India),

Shanghai Medicon Inc (China),

Creative Biorray (US)

Insphero (Switzerland)

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

Gain authentic and granular data access for In Vitro Toxicology market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Direct Purchase of Research Report at: https://www.delvens.com/checkout/in-vitro-toxicology-market-trends-forecast-till-2028

The In Vitro Toxicology Market report answers a number of crucial questions, including:

Which companies dominate the In Vitro Toxicology Market?

What current trends will influence the market over the next few years?

 What are the market's opportunities, obstacles, and driving forces?

What predictions for the future can help with strategic decision-making?

What advantages does market research offer businesses?

Which particular market segments should industry players focus on in order to take advantage of the most recent technical advancements?

What is the anticipated growth rate for the market economy globally?

Read More:

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[market-insider]

Transfer Membranes in Life Sciences Research: Market Analysis and Growth Patterns

The global transfer membrane market size is estimated to reach USD 554.4 million by 2030. Transfer membranes are used for transferring nucleic acids or proteins in blotting techniques such as Western blotting, Southern blotting, Northern blotting, etc. The growing applications of these techniques in gene mapping, DNA fingerprinting, proteomic analysis, etc. are increasing the utility of transfer membranes in the life sciences research industry globally.

Gain deeper insights on the market and receive your free copy with TOC now @: Transfer Membrane Market Report

Moreover, the demand for blotting techniques is growing substantially for the early detection of target diseases and causative agents. These techniques offer high sensitivity and specificity which boosts the adoption of transfer membranes for several diagnostics purposes. Hence, the growing demand for blotting membranes for detecting HIV infection, bovine spongiform encephalopathy, feline immunodeficiency virus infection, HBV infection, etc. is expected to boost the market growth. Similarly, the rising focus and rapid advancements in the development of novel therapies for the treatment of such disorders is anticipated to drive the market growth.

Furthermore, techniques such as Southern blotting are used for the identification of specific DNA sequences in a DNA sample and hence have applications in the recombinant DNA technology where they are used for the isolation of specific DNA fragments. It is also used in academic research studies aimed at identifying mutations and gene rearrangements to better understand neonatal and genetic diseases. Such widespread applications of the technique have led to an established market presence of transfer membranes which can positively affect the market growth in the near future.

[healthcaremarketfmi]

Catheter-Directed Thrombolysis Market Key Drivers and Restraints, Opportunities, Industry Share & Trend Analysis Report to 2032

The global catheter-directed thrombolysis market is expected to be worth US$ 432.0 million in 2022, rising at a 5.9% CAGR to be worth US$ 814.0 million by 2032.

Catheter-directed Thrombolysis Infection Market: Drivers and Restraints

The primary factor driving the growth of catheter-directed thrombolysis market is increasing the prevalence of stroke, pulmonary embolism and deep vein thrombosis around the globe. Besides that, the rising incidences of obesity along increasing geriatric population will propel the growth of catheter-directed thrombolysis market.

Moreover, the availability of emergency medical services and favourable health insurance coverage will also upsurge the growth of catheter-directed thrombolysis market. The scarcity of high health infrastructure in low economic countries will restrain the growth of catheter-directed thrombolysis market over the forecast period. Furthermore, a minor risk associated with the catheter-directed thrombolysis procedure will also restrain the growth of this market to some extent.

Thrombolysis is the therapeutic therapy to treat the clots in blot vessel and improve the blood flow to prevent the damage of tissue and organs. Thrombolysis can be done by injection of clot-busting drugs through an intravenous (IV) line or through a catheter which delivers the drugs directly to the blocking sites. Catheter-directed thrombolysis is a minimal invasive treatment which resolves the issue of clotted blood in the blood vessel. When the blood in the body has improper flow, it gets started to coagulate, which results the formation of semi-solid gel or clouting of blood.

The blood clot may continue to grow within the blood vessel and blocks the blood flow within that blood vessel, this may cause the damage of tissue or organ.  The equipment of catheter-directed thrombolysis includes an x-ray camera, catheter, special medications and a medical device is used to dissolve the blood clots.  Along with x-ray camera and catheter, this equipment consists of a radiographic table, one or two x-ray tubes and a monitor to visualize the procedure.

The x-ray imaging is used for guiding the medication to the site of the blood clot. X-ray machine produces the video of entire procedure which may visualize on a monitor. A catheter used during the thrombolysis, long, thin and hollow plastic tube. These catheters are designed in such way that medication can be easily delivered to the blood clotted site. Some other devices are also used with equipment during the procedure, such as ultrasound machine and other devices to monitor the heartbeat and blood pressure.

Catheter-directed Thrombolysis Market: Key Players 

Examples of some of the market participants in Catheter-directed Thrombolysis market identified across the value chain include Angio Dynamics, Inc., Boston Scientific Corporation, iVascular SLU, Straub Medical AG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

For More Information: https://www.futuremarketinsights.com/reports/catheter-directed-thrombolysis-market

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Current Trends/Issues/Challenges

Competition & Companies involved

Value Chain

The regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia-Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Catheter-directed Thrombolysis Market: Segmentation

The global Catheter-directed Thrombolysis market is classified on the basis of delivery mode, indication, end user and geographic region.

Based on delivery mode, Catheter-directed Thrombolysis market is segmented into following:

Directly delivery to blood clot

Positioning medical device at clot site

[the-rachana]

Blood Screening Market Size (2022-2030) Industry Trends, Growth, Challenges, and Forecast: Growth Plus Reports

The global blood screening market is expected to develop considerably during the forecast period. The growth can be due to various factors such as higher blood donation rates, the prevalence of chronic illnesses and infectious diseases, and expanding economies. Other market drivers include the rapid development of new technologies and the introduction of enhanced products. Another beneficial factor in the market is the increase in healthcare initiatives or investments from public and private organizations.

The blood screening market was valued at US$ 2.3 billion in 2021. The market is expected to witness a CAGR of 8.1% from 2022 to 2030.  

Growing chronic illness/disease occurrences also contribute to market expansion. An increase in such incidences is a prime cause of the rise in fatalities. The risk factors include poor eating habits, physical inactivity, and use of cigarettes/tobacco and alcohol. According to the WHO (World Health Organization) report for 2021, nearly 17.9 million people die every year due to chronic diseases such as cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million). Thus, these factors encourage the growth of the market globally.

Download Sample PDF Brochure: https://growthplusreports.com/inquiry/request-sample/blood-screening-market/7907

Key players:

·        Ortho-Clinical Diagnostics Inc.

·        Thermo Fisher Scientific Inc.

·        Abbott Laboratories

·        F. Hoffmann-La Roche AG

·        Grifols S.A.

·        Quotient Technology Inc.

·        Bio-Rad Laboratories Inc.

·        Becton, Dickinson and Company

·        Danaher Corporation (Beckman Coulter)

·        Siemens Healthineers

By Technology:

·        ELISA

·        Western Blot

·        RT-PCR

·        Rapid Test

·        Nucleic Acid Amplification

By Product:

·        Software

·        Instrument

·        Reagent & Kits

Regional Analysis-

·        The Asia-Pacific market is anticipated to grow at a higher CAGR during the forecast period.

·        Major factors contributing to the growth of Blood Screening market in this region include the rising incidence of chronic infectious diseases, rising awareness regarding growing applications of Blood Screening, and increasing research activities in the field of Blood Screening.

·        The emergence of local players and new product launches has also played a critical role in boosting the Blood Screening market in this region.

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.

(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?

(3) What are the major global Blood Screening Market trends influencing the development of the market?

(4) What are the vital results of SWOT analysis of the major players operating in the Blood Screening Market?

(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

Browse the full report now: https://growthplusreports.com/report/blood-screening-market/7907

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

[chemicaltech]

immunoassay Market is set for lucrative growth during 2021-2031

The global immunoassay market was valued at USD 28.0 billion in 2021 and it is anticipated to grow further up to USD 46.3 billion by 2031, at a CAGR of 5.2% during the forecast period.

A test known as an immunoassay uses an antibody or immunoglobulin to measure the concentration of a macromolecule in a solution. The analyte is the term for the discovered large molecule. For medical and scientific purposes, immunoassay is used to measure the number of analytes in serum and urine. To guarantee the correctness of the results acquired, it is also utilized in qualitative, quantitative, and radioactivity procedures. Immunoassays with high specificity and sensitivity are utilized to speed up the reactions.

To Remain 'Ahead' Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS10300

Major Players in the Global Immunoassay Market

The key players studied in the global immunoassay market are Roche Diagnostics Limited, Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Ortho Clinical Diagnostics, BioMrieux, Bio-Rad Laboratories Inc., Sysmex Corporation, and Becton, Dickinson & Company among others.

Global Immunoassay Market Segmentation

By Technology

 ELISA

Fluorescence

Colorimetric

Chemiluminescence

Rapid Test

Western Blot

ELISPOT

PCR

By Product & Service

 Reagents & Kits

Analyzers

Software Services

 Market Trends and Drivers

The rise in chronic and infectious disorders, especially the COVID-19 outbreak, is responsible for the market expansion. Growth will also be aided by the increase in the elderly population, who are more susceptible to infections and chronic diseases. The widespread use of immunoassay techniques in illness diagnostics is a result of a rise in the incidence of chronic ailments such cancer, infections, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases. The prevalence of cancer is gradually rising, which is anticipated to increase need for efficient diagnostic tools like immunoassay. This method is important for determining oncogenesis and diagnosing cancer in all of its forms, including benign and malignant cancer.

 About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm

headquartered in Delaware, US. We are committed to providing our clients

with highest quality data, analysis, and tools to meet all their market research

needs. With GIS, you can be assured of the quality of the deliverables, robust

and transparent research methodology, and superior service.

 Contact Us:

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: info@globalinsightservices.com

Phone: +1-833-761-1700

[qrtumb]

Global Diagnostic Specialty Antibodies Market Trends, Analysis, and Report

Global Diagnostic Specialty Antibodies Market was valued at USD 25.2 billion in 2021 and it is expected to reach 29.56 billion by 2027 at a CAGR 4.5%.

Diagnostic Specialty Antibodies Market Industry Analysis, Market Size, Market Share, Growth, Trends, and Forecasts 2021-2027 was recently published by Qualiket Research. With market data tables, a Pie Chat, Graphs and Figures distributed across Pages, and an easy-to-understand thorough analysis, Diagnostic Specialty Antibodies Market is a must-have resource. The data is compiled using current floats & requests associated with administrations and items.

The Diagnostic Specialty Antibodies Market Analysis also includes a pioneering landscape of the market, as well as market augmentation history & significant industry developments. In addition, the report includes a complete research study for industries with significant development potential, as well as a professional survey & market analysis. Diagnostic Specialty Antibodies Market Report aids businesses in comprehending market patterns & future market prospects, as well as articulating important business plans.

Get a Sample Copy of This Report@ https://qualiketresearch.com/request-sample/Diagnostic-Specialty-Antibodies-Market/request-sample

Major Key players in this Market:

F. Hoffman La Roche Ltd, Bio-Rad Laboratories, Inc., Creative Diagnostics, Merck KGaA, Agilent Technologies, Inc., Becton, Dickinson and Company, Santa Cruz Biotechnology, Novus Biologicals, LLC, and Thermo Fisher Scientific Inc.

Geographical segmentation of Diagnostic Specialty Antibodies Market involves the regional outlook which further covers North America, Latin America, Europe, Asia-Pacific, Middle East & Africa. This report categorizes the market based on type, clonality, technique, conjugate, application, and region.  

Get Discount on this Report@ https://qualiketresearch.com/request-sample/Diagnostic-Specialty-Antibodies-Market/ask-for-discount

Market Taxonomy

By Type

Primary Antibodies

Secondary Antibodies

By Clonality

Monoclonal Antibodies

Polyclonal Antibodies

Recombinant Antibodies

By Technique

ELISA

Lateral Flow Assay

Immunohistochemistry (IHC)

Immunoprecipitation (IP)

Western Blot (WB)

Immunocytochemistry (ICC)

Other Techniques

By Conjugate

Conjugated Antibodies

Unconjugated Antibodies

By Application

Infectious Diseases

Oncology

Pregnancy Detection/Fertility Testing

Other Applications

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Browse Full Report https://qualiketresearch.com/reports-details/Diagnostic-Specialty-Antibodies-Market

[databridgemarket456]

Global DNA Markers Market – Industry Trends and Forecast to 2028

DNA markers market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 10.91% in the forecast period of 2021 to 2028 and is expected to reach USD 283.20 million by 2028. The growth in popularity of personalized medicine for the treatment of genetic disorders and chronic diseases is escalating the growth of DNA markers market.

The winning DNA MARKERS market report performs geographical analysis for the major areas such as North America, China, Europe, Southeast Asia, Japan, and India, with respect to the production, price, revenue and market share for top manufacturers. This market document is composed of myriad of factors that have an influence on the market and include industry insight and critical success factors (CSFs), market segmentation and value chain analysis, industry dynamics, market drivers, market restraints, key opportunities, technology and application outlook, country-level and regional analysis, competitive landscape, company market share analysis, and key company profiles. The finest DNA MARKERS market report describes CAGR value fluctuation during the forecast period of 2021-2028 for the market. It is the most suitable, rational, and admirable market research report provided with a devotion and comprehension of business needs. The market report also comprises drivers and restraints for the market that are obtained with the help of SWOT analysis and also show all the recent developments, product launches, joint ventures, mergers, and acquisitions by the several key players and brands with their systemic company profiles that are driving the market. DNA MARKERS is the most capable market research report which has been prepared in the way anticipated.

DNA Markers Market Scope and Market Size

DNA markers market is segmented on the basis of product, type, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

On the basis of product, the DNA markers market is segmented into below 50 bp, 50 bp to 100 bp, 100 bp to 1 kb, 1 kb to 5 kb and above 5 kb.

On the basis of type, the DNA markers market is segmented into prestained markers, unstained markers and specialty markers.

On the basis of application, the DNA markers market is segmented into nucleic acid applications and proteomics applications. Nucleic acid applications are further segmented into PCR, sequencing, northern blotting, southern blotting, molecular cloning and others. Proteomics applications are further segmented into western blotting, gel extraction and others.

On the basis of end users, the DNA markers market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, CROs and others.

Get the free sample copy of complete report here:

 

Market Analysis and Insights: Global DNA Markers Market

DNA markers market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 10.91% in the forecast period of 2021 to 2028 and is expected to reach USD 283.20 million by 2028. The growth in popularity of personalized medicine for the treatment of genetic disorders and chronic diseases is escalating the growth of DNA markers market.

DNA markers refer to a DNA sequence or gene with a known location on a chromosome and related to a certain gene or trait. Genetic elements such as DNA sequence or chromosome feature, locus and allele which can be easily detected or identified by cytological or molecular techniques and phenotype and follows chromosomal segment or chromosome during genetic analysis is known as a marker.

The rise in the adoption rate of personalized medicine among population globally and increase in the emphasis on molecular biology research activities are major factors driving the DNA markers market. The demand is also influenced by the increase in technical advances in molecular biology products, including PCR and NGS, coupled with high-quality molecular weight markers. The increase in the investment and funding in research and development programs by biotechnology companies and pharmaceutical companies and rise in funding in life science research by public organizations positively affect the market. New innovations in genomics and proteomics research projects accelerate the market growth. Additionally, the growing collaborations among academic, pharmaceutical and biotechnology companies for molecular research also act as driving factors for DNA markers market. Furthermore, emergence of untapped markets extends profitable opportunity to the market players in the forecast period of 2021 to 2028.

Global DNA Markers Market Country Level Analysis

The countries covered in the DNA markers market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

 DNA Markers Market Share Analysis

DNA markers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to DNA markers market.

Key Players in DNA markers market

The major players covered in the DNA markers market report are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biogen, Illumina, Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific, New England Biolabs., Promega Corporation., Affymetrix microarray solutions, QIAGEN, Takara Bio Inc., Abcam plc., Aline Biosciences, Arc Bio, LLC., MicroGen Diagnostics., Phalanx Biotech Group., Quantum Biosystems, Trace Genomics, Inc., ALLSEQ, INC., among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

MAJOR TOC OF THE REPORT

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insights

Chapter Six: DNA markers market

Get full Access of report

Get Toc of Report:

Browse Related Reports@

Global Chromatography Columns Market – Industry Trends and Forecast to 2029

Global Orthopedic Surgical Robots Market – Industry Trends and Forecast to 2029

The Global Insulin Storage Device Market

Global Surgery Device Market – Industry Trends and Forecast to 2027

Global DNA Markers Market – Industry Trends and Forecast to 2028

Global Neurorehabilitation Gaming Systems Market – Industry Trends and Forecast to 2028

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[delvenservices]

Respiratory Syncytial Virus Diagnostic Market Growth Leaders, Value & Revenue Analysis: 2030

The Respiratory Syncytial Virus Diagnostic Market is Segmented by Product (Kits and Reagents, Instruments, and Others), Method (Molecular Diagnostics, Rapid Antigen Detection Tests, Immunoassays, Flow Cytometry, Chromatography), End User (Hospitals and Clinics, Clinical Laboratories, and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

Market Overview

The global Respiratory Syncytial Virus market size was estimated at USD 1.05 billion in 2023 and is projected to reach USD 2.2 billion in 2030 at a CAGR of 10.4% during the forecast period 2023-2030.

The respiratory virus known as respiratory syncytial virus (RSV) attacks the lungs and bronchioles. The majority of children become unwell from it by the age of two, making it one of the prevalent causes of childhood disease. Adults can also contract RSV. Pneumonia and bronchitis are among the more serious RSV infections. One of the main drivers of market expansion is the rising sickness rate.

Modern technologies like bio- and nanotechnology are helping to develop current RSV detection procedures including the western blot, enzyme-linked immunosorbent test (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). In addition, government organizations from many nations provide funding for R&D initiatives to create novel treatments. An increase in the number of clinical vaccination studies, an increase in the need for in-vitro diagnostics, an increase in the prevalence of pediatric pneumonia, and an increase in the usage of molecular diagnostics are other factors anticipated to propel the market.

When infants under two years of age experience severe respiratory symptoms, RSV infection is more risky. One of the major drivers propelling market expansion is this, together with parents' increasing attention on providing for the medical needs of their children. Moreover, variables that promote development include the high survival rates following early diagnosis and the accessibility to diagnostic tools. In addition, expanding healthcare infrastructure and favorable newborn hospital reimbursement policies are propelling market expansion.

In hospitals, the use of multiplex diagnostic panels has grown for the early and quick diagnosis of COVID-19 in severely sick respiratory patients. These panels include diagnostic for COVID-19 and RSV infections during the pandemic. The consequences of COVID-19 on diagnostic procedures are extensive and include labor force and staffing issues, procedural prioritization, and danger of intraoperative viral transmission. Multiplex diagnostics have been crucial in giving speedy findings for COVID-19 diagnostics, despite the fact that COVID-19 has caused a lack of crucial diagnostic tests during the early pandemic.

Get the Free Sample Copy: https://www.delvens.com/get-free-sample/respiratory-syncytial-virus-market-trends-forecast-till-2030

Delvens Industry Expert's Standpoint

Modern technologies like bio- and nanotechnology are helping to develop current RSV detection procedures including the western blot, enzyme-linked immunosorbent test (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). In addition, government organizations from many nations provide funding for R&D initiatives to create novel treatments. A rise in the number of clinical vaccination studies, an increase in the need for in-vitro diagnostics, an increase in the prevalence of pediatric pneumonia, and a rise in the use of molecular diagnostics are additional factors anticipated to propel the market. These are the specific elements that fuel market expansion. When infants under two years of age experience severe respiratory symptoms, RSV infection is more risky. One of the major drivers propelling market expansion is this, together with parents' increasing attention on providing for the medical needs of their children. Moreover, variables that promote development include the high survival rates following early diagnosis and the accessibility to diagnostic tools.

Key Findings

Based on medication type, Synagis held the greatest market share of more than 32% in the global market. A medication called Synagis is used to prevent the severe respiratory syncytial virus in vulnerable children and newborns. Furthermore, throughout the course of the projection period, Virazole is anticipated to see the quickest rate of growth. In the worldwide RSV market, the injectable dosage form category has the biggest market share. Also, during the evaluation period, the oral section is anticipated to increase at the quickest rate.

Throughout the projected period, the category with the strongest growth is anticipated to be antiviral medications. The sector growth is anticipated to be supported by the rising hospitalization rate for RSV as a result of the rising illness prevalence. Based on distribution channel, the hospital pharmacies category has the largest market share globally. Hospital pharmacies are the ideal distribution route since all sorts of pharmaceuticals are easily accessible there.  

Throughout the study period, it is anticipated that the increasing product releases, research studies examining the advantages of quick antigen testing over other techniques, and significant government and industry-level initiatives will all contribute to the segment's growth. According to a study published in February 2022 titled "Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults," the positive percentage agreement of the rapid antigen test Xpert Xpress Flu/RSV compared to standard RT-PCR is high for RSV detection in older people who live at home. At the point of care, the assay is quick and simple to use. These Tremendous benefits will fuel the market's expansion.  

The respiratory syncytial virus (RSV) diagnostic market is dominated by North America due to the rise in RSV infections. In the projected period of 2023 to 2030, Asia-Pacific is anticipated to develop at the fastest rate due to rising population densities and an increase in the prevalence of infectious illnesses. Additionally, the respiratory syncytial virus (RSV) diagnostic market is anticipated to rise in the approaching years due to the region's developing healthcare systems and expanding number of government initiatives.

Make an Inquiry Before the Purchase: https://www.delvens.com/Inquire-before-buying/respiratory-syncytial-virus-market-trends-forecast-till-2030

Regional Analysis

North America to Dominate the Market

The respiratory syncytial virus (RSV) diagnostic market is dominated by North America due to the rise in RSV infections. Also, the region's rising infant mortality rate and expanding number of key alliances.  

The respiratory syncytial virus (RSV) diagnostic market will be driven by the region's expanding newborn population as well as the rising number of strategic alliances between pharmaceutical giants and in vitro diagnostic manufacturing firms over the course of the forecast period.

Competitive Landscape

BIOMERIEUX

Abbott

F. Hoffman La. Roche Ltd

Danaher

Thermo Fisher Scientific Inc.

Luminex Corporation

BioCartis,

Hologic, Inc.

Fast Track Diagnostics Luxembourg S.à r.l.

Beckman Coulter Inc.

Ortho-Clinical Diagnostics

Bio-Rad Laboratories Inc.

DiaSorin S.p.A.

Becton, Dickinson and Company

AbbVie, Inc.

AstraZeneca PLC

Atea Pharmaceuticals

Bausch Health Companies Inc.

Celltrion Inc.

Enanta Pharmaceuticals, Inc

Recent Developments

In April 2022, Allplex RV Master Assay acquired the European CE-IVD certification and clearance from Australia's Therapeutic Goods Administration, according to a release from Seegene Inc. in April 2022. It can discriminate between two kinds of respiratory syncytial viruses and 21 targets for 19 distinct respiratory viruses.  

In March 2022, SARS-CoV-2, influenza A and B, respiratory syncytial virus, and Pandemic Response Lab (PRL), a wholly-owned subsidiary of Opentrons Labworks Inc., introduced a condensed respiratory panel in March 2022. (RSV).

Purchase the Report: https://www.delvens.com/checkout/respiratory-syncytial-virus-market-trends-forecast-till-2030

Reasons to Acquire

Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.  

Gain authentic and granular data access for the Respiratory Syncytial Virus Market to understand the trends and the factors involved in changing market situations.  

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.  

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope

The Respiratory Syncytial Virus Market is segmented into various segments such as Product, Method, End User, Drug type, Dosage Form, Distribution channel, and region:

Based on Product

Kits and Assays

Instruments

Others

Based on the Method

Molecular Diagnostics

Rapid Antigen Detection Tests

Immunoassays

Flow Cytometry

Chromatography

Others

Based on the End User

Hospitals and Clinics

Clinical Laboratories

Others

Based on Drug type

Ribavirin

Synagis

Virazole

Palivizumab

Riba Tab

Others

Based on Dosage Form

Oral

Injectable

Inhaler

Other

Based on Distribution Channel

Hospital pharmacies

Drug Stores

Retail pharmacies

Clinics

Based on region

Asia Pacific  

Japan

China

India

Australia

South Korea

Vietnam

New Zealand

Philippines

Thailand

Malaysia

Hong Kong

Taiwan

Singapore

Indonesia

Sri Lanka

Rest of Asia-Pacific

North America  

U.S.

Canada

Mexico

Europe  

Germany

U.K.

France

Italy

Spain

Sweden

Austria

Finland

Belgium

Turkey

Russia

Poland

Hungary

Czech Republic

Switzerland

Netherlands

Rest of Europe

South America  

Brazil

Argentina

Chile

Colombia

Rest of South America

Middle East & Africa  

South Africa

U.A.E.

Saudi Arabia

Oman

Qatar

Iran

Egypt

Rest of Middle East and Africa

The prominent players in the Respiratory Syncytial Virus market are

BIOMERIEUX

Abbott

F. Hoffman La. Roche Ltd

Danaher

Thermo Fisher Scientific Inc.

Luminex Corporation

BioCartis, Hologic, Inc.

Fast Track Diagnostics Luxembourg S.à r.l.

Beckman Coulter Inc.

Ortho-Clinical Diagnostics

Bio-Rad Laboratories Inc.

DiaSorin S.p.A.

Becton, Dickinson and Company

AbbVie, Inc.

AstraZeneca PLC

Atea Pharmaceuticals

Bausch Health Companies Inc.

Celltrion Inc.

Enanta Pharmaceuticals, Inc

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[kiransharma123]

Global Western Blotting Market Intelligence and Forecast by Future market Insight 2019-2024

Analysis: Western Blotting Market

The Western Blotting Market accounted to USD 728.3 million in 2016 growing at a CAGR of 5.10% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Major Market Competitors included: Western Blotting Market

Some of the major players operating in western blotting market are

Thermo Fisher Scientific, Inc. (U.S.)

Advansta, Inc. (U.S.)

Bio-Rad Laboratories

GE Healthcare (U.S.)

LI-COR Inc. (U.S.)

Merck KGaA (Germany)

PerkinElmer, Inc. (U.S.)

Major Market Drivers and Restraints:

Rising pervasiveness of HIV, and Lyme

Expanding interest in R&D by different pharmaceuticals companies.

Extending the application in the field of proteomics

Definition: Western Blotting Market

Western blotting is a technique used for detecting and analysing the protein molecules in the given complex sample which is separated according to size, weight and by using electrophoresis. Further process of analysis is transferred into another membrane of the western blot which commonly consists of nitrocellulose or polyvinylidene difluoride (PVDF).

Segmentation: Western Blotting Market

On the basis of product type, western blotting market is segmented into instruments and consumables. In 2016, consumable segment was leading the market share and is expected to grow in the forecast period due to increase in R&D activities in coming period.

On the basis of application, western blotting market is segmented into biomedical & biochemical research and disease diagnostics. Due to vast expenditure by government in proteomics research, biomedical & biochemical research has contributed towards the largest share in 2016.

On the basis of end users, western blotting market is segmented into academic & research institutes, and pharmaceutical & biotechnology companies. In 2016, academic & research institutes dominated the market owing to growing number of research activities conducted by educational institutions supported by government funding. However pharmaceutical and biotechnology companies are expected to grow at a significant CAGR over the forecast period due to increasing R&D spending by such companies.

Competitive Analysis: Western Blotting Market

The western blotting market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes western blotting market shares for global, Europe, North America, Asia Pacific and South America.

READ MORE

Contact:

Data Bridge Market Research

Email: info@databridgemarketresearch.com

Tel: +1-888-387-2818